Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth
- 1 June 2001
- journal article
- alimentary tract
- Published by Elsevier BV in Gastroenterology
- Vol. 120 (7), 1713-1719
- https://doi.org/10.1053/gast.2001.24844
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- New directions in the treatment of colorectal cancer: a look to the futureEuropean Journal Of Cancer, 2000
- Localization of Cyclooxygenase-2 in Human Sporadic Colorectal AdenomasThe American Journal of Pathology, 2000
- Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cellsOncogene, 1999
- Regulation of Cyclooxygenase-2 pathway by HER2 receptorOncogene, 1999
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- Real time quantitative PCR.Genome Research, 1996
- Isolation and characterization of multiple cell types from a single human colonic carcinoma: Tumourigenicity of these cell types in a xenograft systemThe Journal of Pathology, 1993
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987